Promino Nutritional Sciences Inc.
MUSL
CNSX
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 1.23M | 719.90K | 355.40K | 189.40K | 180.70K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 1.23M | 719.90K | 355.40K | 189.40K | 180.70K |
| Cost of Revenue | 1.13M | 811.60K | 548.20K | 433.30K | 726.20K |
| Gross Profit | 106.70K | -91.60K | -192.70K | -243.80K | -545.40K |
| SG&A Expenses | 1.07M | 1.84M | 3.38M | 5.13M | 8.34M |
| Depreciation & Amortization | -- | -- | -- | -- | 5.40K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 2.23M | 2.73M | 4.00M | 5.64M | 9.13M |
| Operating Income | -999.10K | -2.01M | -3.65M | -5.45M | -8.95M |
| Income Before Tax | -1.05M | -2.55M | -3.59M | -5.46M | -8.52M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -1.05 | -2.55 | -3.59 | -5.46 | -8.52 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -1.05M | -2.55M | -3.59M | -5.46M | -8.52M |
| EBIT | -999.10K | -2.01M | -3.65M | -5.45M | -8.95M |
| EBITDA | 431.40K | -941.20K | -3.16M | -5.43M | -8.93M |
| EPS Basic | -0.01 | -0.02 | -0.05 | -0.09 | -0.16 |
| Normalized Basic EPS | -0.01 | -0.01 | -0.03 | -0.05 | -0.10 |
| EPS Diluted | -0.01 | -0.02 | -0.05 | -0.09 | -0.16 |
| Normalized Diluted EPS | -0.01 | -0.01 | -0.03 | -0.05 | -0.10 |
| Average Basic Shares Outstanding | 505.52M | 469.06M | 397.84M | 332.34M | 259.54M |
| Average Diluted Shares Outstanding | 505.52M | 469.06M | 397.84M | 332.34M | 259.54M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |